KRTL BioTech

Firm Size and Innovation: A Double-Edged Sword

Firm Size and Innovation: A Double-Edged Sword

New Things Under the Sun | Matt Clancy | Jun 2, 2023 Recent studies highlight that as firms grow in size, their R&D expenditures rise proportionally with sales, but they tend to produce fewer groundbreaking innovations per R&D dollar spent. Large firms, often termed "superfirms", are more focused on incremental innovations, primarily aimed at improving


The post Firm Size and Innovation: A Double-Edged Sword first appeared on National Crowdfunding & Fintech Association of Canada.